Litcius/Paper detail

Efficacy and acceptability of anti-inflammatory eicosapentaenoic acid for cognitive function in Alzheimer’s dementia: A network meta-analysis of randomized, placebo-controlled trials with omega-3 fatty acids and FDA-approved pharmacotherapy

Ping‐Tao Tseng, Bing‐Syuan Zeng, Mein‐Woei Suen, Yi‐Cheng Wu, Christoph U. Correll, Bing‐Yan Zeng, John S. Kuo, Yen‐Wen Chen, Tien‐Yu Chen, Yu‐Kang Tu, Pao‐Yen Lin, André F. Carvalho, Brendon Stubbs, Dian‐Jeng Li, Chih‐Sung Liang, Chih‐Wei Hsu, Cheuk‐Kwan Sun, Yu‐Shian Cheng, Pin‐Yang Yeh, Ming‐Kung Wu, Yow‐Ling Shiue, Kuan‐Pin Su, Kuan‐Pin Su

2023Brain Behavior and Immunity37 citationsDOIOpen Access PDF

Topics & Concepts

MedicineEicosapentaenoic acidTolerabilityRandomized controlled trialInternal medicineDementiaPlaceboPolyunsaturated fatty acidDiscontinuationAdverse effectOmega 3 fatty acidOdds ratioPsychiatryDocosahexaenoic acidDiseaseFatty acidPathologyBiologyAlternative medicineBiochemistryFatty Acid Research and HealthAlcoholism and Thiamine DeficiencyDiet and metabolism studies
Efficacy and acceptability of anti-inflammatory eicosapentaenoic acid for cognitive function in Alzheimer’s dementia: A network meta-analysis of randomized, placebo-controlled trials with omega-3 fatty acids and FDA-approved pharmacotherapy | Litcius